Charles Grob, M.D.
Charles S. Grob, M.D., is the Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of Psychiatry and Pediatrics at the UCLA School of Medicine. He conducted the first government-approved psychobiological research study of MDMA, and was the principal investigator of an international biomedical- psychiatric research project in the Brazilian Amazon of the plant hallucinogen ayahuasca. Over the last several years he has conducted a comprehensive research assessment of the safety and efficacy of psilocybin in the treatment of advanced-cancer patients with existential anxiety. Dr. Grob is the editor of Hallucinogens: A Reader (Tarcher/ Putnam, 2002) and the co-editor (with Roger Walsh) of Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (SUNY Press, 2005). He has published numerous articles in medical and psychiatric journal and collected volumes. He is a founding board member of the Heffter Research Institute.